In addition, YAP1 promotes resistance to chemotherapy, targeted therapy, and hormone therapy through the upregulation of several pro-survival and antiapoptotic genes, and they also influence responses to immunotherapy by modulating the tumor immune microenvironment [37, 38]. The gene discussed is YAP1; the disease is neoplasm.